- Home
- CING
CING
Cingulate Inc.
as 11-15-2024 4:00pm EST
| Founded: | 2012 | Country: | United States |
| Employees: | N/A | City: | KANSAS CITY |
| Market Cap: | N/A | IPO Year: | 2021 |
| Target Price: | $96.00 | AVG Volume (30 days): | 205.7K |
| Analyst Decision: | Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -22.31 | EPS Growth: | N/A |
| 52 Week Low/High: | $1.80 - $152.40 | Next Earning Date: | 11-07-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Cingulate Inc. News
CING Breaking Stock News: Dive into CING Ticker-Specific Updates for Smart Investing
Zacks Small Cap Research
6 days ago
CING: Third Quarter Results
GlobeNewswire
10 days ago
Cingulate Reports Third Quarter 2024 Financial Results Reflecting $19.5 Million Increase in Working Capital to Advance ADHD Drug to Market
GlobeNewswire
a month ago
Cingulate’s Shane Schaffer Joins Cast of Nationally Syndicated Big Biz Show
GlobeNewswire
2 months ago
Cingulate Initiates Final Study for Lead ADHD Asset CTx-1301
GlobeNewswire
3 months ago
Cingulate to Participate in Benzinga All Live Access Event
Zacks Small Cap Research
3 months ago
CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage
Zacks Small Cap Research
3 months ago
CING: Initiating Coverage – Precision Timed Release Delivers Active-Day Coverage
GlobeNewswire
3 months ago
Cingulate Announces Adjournment of Special Meeting
Compare CING vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "CING Cingulate Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.